bf/NASDAQ:INSM_icon.jpeg

NASDAQ:INSM

Insmed Incorporated

  • Stock

72.64

+0.89%

−50.23

USD last updated 14/08 01:46:41

Last Close

122.87

13/08 22:31

Market Cap

11.79B

Beta: 1.53

Volume Today

1.79M

Avg: 1.23M

PE Ratio

−5.60

PFCF: −7.74

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptida...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1.5-1-0.52018-08-022020-02-252021-10-282023-05-042024-10-31

    Revenue (Estimate*)

    20M40M60M80M100M2018-08-022020-02-252021-10-282023-05-042024-10-31

    *Estimate based on analyst consensus